The Valley Desk

NCT05329649 · Interventional trial

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

Overall registry status Active not recruiting

Phase 3

Conditions Hematological Diseases, Hemoglobinopathies, Hydroxyurea Failure, Hydroxyurea Intolerance, Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov